Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,642 | 2,825 | 2,110 | 1,395 | 947 |
| Operating Income | -1,642 | -2,825 | -2,110 | -1,395 | -947 |
| Interest Expense | 140 | 92 | 67 | 69 | 68 |
| Other Income | 0 | 0 | -3 | -20 | 0 |
| Pre-tax Income | -1,782 | -2,917 | -2,180 | -1,484 | -1,016 |
| Net Income Continuous | -1,782 | -2,917 | -2,180 | -1,484 | -1,016 |
| Net Income | $-1,782 | $-2,917 | $-2,180 | $-1,484 | $-1,016 |
| EPS Basic Total Ops | -0.08 | -0.18 | -0.20 | -0.20 | -0.10 |
| EPS Basic Continuous Ops | -0.08 | -0.18 | -0.20 | -0.20 | -0.10 |
| EPS Diluted Total Ops | -0.08 | -0.18 | -0.20 | -0.20 | -0.10 |
| EPS Diluted Continuous Ops | -0.08 | -0.18 | -0.20 | -0.20 | -0.10 |
| EBITDA(a) | $-1,507 | $-2,692 | $-1,981 | $-1,280 | $-813 |